ArticleAIDS and behavior2026
Social and Healthcare Disruptions Due to the COVID-19 Pandemic and Associations with Psychosocial Well-Being Among Cancer Survivors With and Without HIV: Findings from the MACS/WIHS Combined Cohort Study.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
People with HIV (PWH) with a history of cancer are more likely to experience poor psychosocial well-being compared to those without HIV. This study aims to assess the associations between social and healthcare disruptions due to the COVID-19 pandemic with psychosocial well-being among cancer survivors with and without HIV. A cross-sectional survey was conducted between April and September 2020 among participants of the MACS/WIHS Combined Cohort Study with a history of cancer. The primary exposures were social disruptions (loss of job, child care, financial support, housing, and health insurance) and healthcare disruptions (unable to attend a healthcare appointment, obtain medications, and afford medical care). Psychosocial outcomes included depressive symptoms, anxiety symptoms, stress, loneliness, social support, social support satisfaction, and resilient coping. We estimated adjusted prevalence ratios (aPRs) with 95% confidence intervals (95% CIs) using multivariable Poisson regression. Cancer survivors (N = 452) included 63.7% PWH and 51.5% men. Overall, PWH were more likely to experience social disruptions compared to those without HIV (49.6% vs. 36.6%; p = 0.008). Among cancer survivors with HIV, two or more social disruptions were associated with high depressive symptoms (aPR = 2.19, 95% CI = 1.56, 3.08), anxiety symptoms (aPR = 2.36, 95% CI = 1.25, 4.48), stress (aPR = 3.32, 95% CI = 1.25, 8.79), and loneliness (aPR = 2.16, 95% CI = 1.25, 3.74), and one or more healthcare disruptions were associated with high depressive symptoms (aPR = 1.53, 95% CI = 1.22, 1.94), stress (aPR = 2.92, 95% CI = 1.53, 5.58), loneliness (aPR = 1.78, 95% CI = 1.23, 2.57), and low social support (aPR = 1.75, 95% CI = 1.08, 2.82). Disruptions were associated with poorer mental health among PWH but not among people without HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.